Compare Stocks

3 / 10
Try these comparisons:

Stock Comparison

ADUS vs HCSG vs ENSG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ADUS
Addus HomeCare Corporation

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.80B
5Y Perf.-2.3%
HCSG
Healthcare Services Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.58B
5Y Perf.-7.7%
ENSG
The Ensign Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$10.28B
5Y Perf.+302.4%

ADUS vs HCSG vs ENSG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ADUS logoADUS
HCSG logoHCSG
ENSG logoENSG
IndustryMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$1.80B$1.58B$10.28B
Revenue (TTM)$1.45B$1.84B$5.27B
Net Income (TTM)$100M$59M$363M
Gross Margin32.5%13.3%15.2%
Operating Margin9.8%3.0%8.5%
Forward P/E14.0x20.6x23.4x
Total Debt$209M$25M$4.15B
Cash & Equiv.$82M$161M$504M

ADUS vs HCSG vs ENSGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ADUS
HCSG
ENSG
StockMay 20May 26Return
Addus HomeCare Corp… (ADUS)10097.7-2.3%
Healthcare Services… (HCSG)10092.3-7.7%
The Ensign Group, I… (ENSG)100402.4+302.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: ADUS vs HCSG vs ENSG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ENSG leads in 3 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Addus HomeCare Corporation is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
ADUS
Addus HomeCare Corporation
The Growth Play

ADUS is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 23.2%, EPS growth 23.2%, 3Y rev CAGR 14.4%
  • Lower volatility, beta 0.58, Low D/E 19.2%, current ratio 1.80x
  • PEG 0.70 vs ENSG's 1.70
Best for: growth exposure and sleep-well-at-night
HCSG
Healthcare Services Group, Inc.
The Momentum Pick

HCSG is the clearest fit if your priority is momentum and efficiency.

  • +53.4% vs ADUS's -11.0%
  • 7.3% ROA vs ENSG's 6.8%, ROIC 9.0% vs 7.0%
Best for: momentum and efficiency
ENSG
The Ensign Group, Inc.
The Income Pick

ENSG has the current edge in this matchup, primarily because of its strength in income & stability and long-term compounding.

  • Dividend streak 12 yrs, beta 0.42, yield 0.1%
  • 7.7% 10Y total return vs ADUS's 427.2%
  • Beta 0.42, yield 0.1%, current ratio 1.42x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthADUS logoADUS23.2% revenue growth vs HCSG's 7.1%
ValueADUS logoADUSLower P/E (14.0x vs 23.4x), PEG 0.70 vs 1.70
Quality / MarginsENSG logoENSG6.9% margin vs HCSG's 3.2%
Stability / SafetyENSG logoENSGBeta 0.42 vs HCSG's 1.12
DividendsENSG logoENSG0.1% yield; 12-year raise streak; the other 2 pay no meaningful dividend
Momentum (1Y)HCSG logoHCSG+53.4% vs ADUS's -11.0%
Efficiency (ROA)HCSG logoHCSG7.3% ROA vs ENSG's 6.8%, ROIC 9.0% vs 7.0%

ADUS vs HCSG vs ENSG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ADUSAddus HomeCare Corporation
FY 2025
Personal Care
76.6%$1.1B
Hospice
18.5%$263M
Home Health
5.0%$71M
HCSGHealthcare Services Group, Inc.
FY 2025
Dietary Services
55.1%$1.0B
Environmental Services
44.9%$825M
ENSGThe Ensign Group, Inc.
FY 2025
Skilled Services Segment
97.4%$4.8B
Standard Bearer Segment
2.6%$127M

ADUS vs HCSG vs ENSG — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLADUSLAGGINGENSG

Income & Cash Flow (Last 12 Months)

ADUS leads this category, winning 3 of 6 comparable metrics.

ENSG is the larger business by revenue, generating $5.3B annually — 3.6x ADUS's $1.4B. Profitability is closely matched — net margins range from 6.9% (ENSG) to 3.2% (HCSG). On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricADUS logoADUSAddus HomeCare Co…HCSG logoHCSGHealthcare Servic…ENSG logoENSGThe Ensign Group,…
RevenueTrailing 12 months$1.4B$1.8B$5.3B
EBITDAEarnings before interest/tax$159M$72M$558M
Net IncomeAfter-tax profit$100M$59M$363M
Free Cash FlowCash after capex$137M$139M$406M
Gross MarginGross profit ÷ Revenue+32.5%+13.3%+15.2%
Operating MarginEBIT ÷ Revenue+9.8%+3.0%+8.5%
Net MarginNet income ÷ Revenue+6.9%+3.2%+6.9%
FCF MarginFCF ÷ Revenue+9.5%+7.6%+7.7%
Rev. Growth (YoY)Latest quarter vs prior year+7.7%+6.6%+18.4%
EPS Growth (YoY)Latest quarter vs prior year+17.2%+175.0%+21.9%
ADUS leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

ADUS leads this category, winning 5 of 7 comparable metrics.

At 18.5x trailing earnings, ADUS trades at a 38% valuation discount to ENSG's 30.1x P/E. Adjusting for growth (PEG ratio), ADUS offers better value at 0.92x vs ENSG's 2.18x — a lower PEG means you pay less per unit of expected earnings growth.

MetricADUS logoADUSAddus HomeCare Co…HCSG logoHCSGHealthcare Servic…ENSG logoENSGThe Ensign Group,…
Market CapShares × price$1.8B$1.6B$10.3B
Enterprise ValueMkt cap + debt − cash$1.9B$1.4B$13.9B
Trailing P/EPrice ÷ TTM EPS18.55x27.25x30.13x
Forward P/EPrice ÷ next-FY EPS est.14.02x20.61x23.40x
PEG RatioP/E ÷ EPS growth rate0.92x2.18x
EV / EBITDAEnterprise value multiple12.44x22.12x25.88x
Price / SalesMarket cap ÷ Revenue1.27x0.86x2.03x
Price / BookPrice ÷ Book value/share1.64x3.16x4.63x
Price / FCFMarket cap ÷ FCF17.36x11.36x27.72x
ADUS leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

HCSG leads this category, winning 6 of 9 comparable metrics.

ENSG delivers a 16.6% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $9 for ADUS. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x. On the Piotroski fundamental quality scale (0–9), ADUS scores 7/9 vs ENSG's 5/9, reflecting strong financial health.

MetricADUS logoADUSAddus HomeCare Co…HCSG logoHCSGHealthcare Servic…ENSG logoENSGThe Ensign Group,…
ROE (TTM)Return on equity+9.3%+11.8%+16.6%
ROA (TTM)Return on assets+7.0%+7.3%+6.8%
ROICReturn on invested capital+8.8%+9.0%+7.0%
ROCEReturn on capital employed+10.9%+7.7%+10.2%
Piotroski ScoreFundamental quality 0–9775
Debt / EquityFinancial leverage0.19x0.05x1.86x
Net DebtTotal debt minus cash$127M-$136M$3.7B
Cash & Equiv.Liquid assets$82M$161M$504M
Total DebtShort + long-term debt$209M$25M$4.2B
Interest CoverageEBIT ÷ Interest expense14.45x33.02x88.33x
HCSG leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ENSG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ENSG five years ago would be worth $20,770 today (with dividends reinvested), compared to $7,863 for HCSG. Over the past 12 months, HCSG leads with a +53.4% total return vs ADUS's -11.0%. The 3-year compound annual growth rate (CAGR) favors ENSG at 24.0% vs ADUS's 4.9% — a key indicator of consistent wealth creation.

MetricADUS logoADUSAddus HomeCare Co…HCSG logoHCSGHealthcare Servic…ENSG logoENSGThe Ensign Group,…
YTD ReturnYear-to-date-9.3%+27.2%+1.2%
1-Year ReturnPast 12 months-11.0%+53.4%+31.9%
3-Year ReturnCumulative with dividends+15.5%+47.0%+90.7%
5-Year ReturnCumulative with dividends+2.6%-21.4%+107.7%
10-Year ReturnCumulative with dividends+427.2%-27.0%+768.3%
CAGR (3Y)Annualised 3-year return+4.9%+13.7%+24.0%
ENSG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — HCSG and ENSG each lead in 1 of 2 comparable metrics.

ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than HCSG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 90.5% from its 52-week high vs ADUS's 77.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricADUS logoADUSAddus HomeCare Co…HCSG logoHCSGHealthcare Servic…ENSG logoENSGThe Ensign Group,…
Beta (5Y)Sensitivity to S&P 5000.58x1.12x0.42x
52-Week HighHighest price in past year$124.44$24.39$218.00
52-Week LowLowest price in past year$90.89$12.66$129.91
% of 52W HighCurrent price vs 52-week peak+77.7%+90.5%+80.7%
RSI (14)Momentum oscillator 0–10054.659.723.3
Avg Volume (50D)Average daily shares traded239K676K352K
Evenly matched — HCSG and ENSG each lead in 1 of 2 comparable metrics.

Analyst Outlook

HCSG leads this category, winning 1 of 1 comparable metric.

Analyst consensus: ADUS as "Buy", HCSG as "Hold", ENSG as "Buy". Consensus price targets imply 33.1% upside for ADUS (target: $129) vs 11.0% for HCSG (target: $25). ENSG is the only dividend payer here at 0.14% yield — a key consideration for income-focused portfolios.

MetricADUS logoADUSAddus HomeCare Co…HCSG logoHCSGHealthcare Servic…ENSG logoENSGThe Ensign Group,…
Analyst RatingConsensus buy/hold/sellBuyHoldBuy
Price TargetConsensus 12-month target$128.67$24.50$222.33
# AnalystsCovering analysts151513
Dividend YieldAnnual dividend ÷ price+0.1%
Dividend StreakConsecutive years of raises22012
Dividend / ShareAnnual DPS$0.24
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.9%+0.2%
HCSG leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ADUS leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). HCSG leads in 2 (Profitability & Efficiency, Analyst Outlook). 1 tied.

Best OverallAddus HomeCare Corporation (ADUS)Leads 2 of 6 categories
Loading custom metrics...

ADUS vs HCSG vs ENSG: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ADUS or HCSG or ENSG a better buy right now?

For growth investors, Addus HomeCare Corporation (ADUS) is the stronger pick with 23.

2% revenue growth year-over-year, versus 7. 1% for Healthcare Services Group, Inc. (HCSG). Addus HomeCare Corporation (ADUS) offers the better valuation at 18. 5x trailing P/E (14. 0x forward), making it the more compelling value choice. Analysts rate Addus HomeCare Corporation (ADUS) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ADUS or HCSG or ENSG?

On trailing P/E, Addus HomeCare Corporation (ADUS) is the cheapest at 18.

5x versus The Ensign Group, Inc. at 30. 1x. On forward P/E, Addus HomeCare Corporation is actually cheaper at 14. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Addus HomeCare Corporation wins at 0. 70x versus The Ensign Group, Inc. 's 1. 70x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — ADUS or HCSG or ENSG?

Over the past 5 years, The Ensign Group, Inc.

(ENSG) delivered a total return of +107. 7%, compared to -21. 4% for Healthcare Services Group, Inc. (HCSG). Over 10 years, the gap is even starker: ENSG returned +768. 3% versus HCSG's -27. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ADUS or HCSG or ENSG?

By beta (market sensitivity over 5 years), The Ensign Group, Inc.

(ENSG) is the lower-risk stock at 0. 42β versus Healthcare Services Group, Inc. 's 1. 12β — meaning HCSG is approximately 166% more volatile than ENSG relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ADUS or HCSG or ENSG?

By revenue growth (latest reported year), Addus HomeCare Corporation (ADUS) is pulling ahead at 23.

2% versus 7. 1% for Healthcare Services Group, Inc. (HCSG). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to 14. 1% for The Ensign Group, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ADUS or HCSG or ENSG?

The Ensign Group, Inc.

(ENSG) is the more profitable company, earning 6. 8% net margin versus 3. 2% for Healthcare Services Group, Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADUS leads at 9. 7% versus 2. 6% for HCSG. At the gross margin level — before operating expenses — ADUS leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ADUS or HCSG or ENSG more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Addus HomeCare Corporation (ADUS) is the more undervalued stock at a PEG of 0. 70x versus The Ensign Group, Inc. 's 1. 70x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Addus HomeCare Corporation (ADUS) trades at 14. 0x forward P/E versus 23. 4x for The Ensign Group, Inc. — 9. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ADUS: 33. 1% to $128. 67.

08

Which pays a better dividend — ADUS or HCSG or ENSG?

In this comparison, ENSG (0.

1% yield) pays a dividend. ADUS, HCSG do not pay a meaningful dividend and should not be held primarily for income.

09

Is ADUS or HCSG or ENSG better for a retirement portfolio?

For long-horizon retirement investors, The Ensign Group, Inc.

(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +768. 3% 10Y return). Both have compounded well over 10 years (ENSG: +768. 3%, HCSG: -27. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ADUS and HCSG and ENSG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ADUS is a small-cap high-growth stock; HCSG is a small-cap quality compounder stock; ENSG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ADUS

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

HCSG

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
Run This Screen
Stocks Like

ENSG

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ADUS and HCSG and ENSG on the metrics below

Revenue Growth>
%
(ADUS: 7.7% · HCSG: 6.6%)
Net Margin>
%
(ADUS: 6.9% · HCSG: 3.2%)
P/E Ratio<
x
(ADUS: 18.5x · HCSG: 27.2x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.